V

VistaGen Therapeutics Inc
NASDAQ:VTGN

Watchlist Manager
VistaGen Therapeutics Inc
NASDAQ:VTGN
Watchlist
Price: 2.21 USD -4.54% Market Closed
Market Cap: 63.8m USD
Have any thoughts about
VistaGen Therapeutics Inc?
Write Note

Wall Street
Price Targets

VTGN Price Targets Summary
VistaGen Therapeutics Inc

Wall Street analysts forecast VTGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VTGN is 13.26 USD with a low forecast of 12.12 USD and a high forecast of 15.75 USD.

Lowest
Price Target
12.12 USD
448% Upside
Average
Price Target
13.26 USD
500% Upside
Highest
Price Target
15.75 USD
613% Upside
VistaGen Therapeutics Inc Competitors:
Price Targets
KNSA
Kiniksa Pharmaceuticals Ltd
30% Upside
EXAS
Exact Sciences Corp
32% Upside
300676
BGI Genomics Co Ltd
6% Upside
RAPT
Rapt Therapeutics Inc
268% Upside
2171
CARsgen Therapeutics Holdings Ltd
56% Downside
300841
Chengdu Kanghua Biological Products Co Ltd
40% Upside
DBV
DBV Technologies SA
150% Upside
NBIX
Neurocrine Biosciences Inc
29% Upside

Revenue
Forecast

Revenue Estimate
VistaGen Therapeutics Inc

The compound annual growth rate of VistaGen Therapeutics Inc's revenue for the next 4 years is 186%.

N/A
Past Growth
186%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
VistaGen Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
VistaGen Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-86%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VTGN's stock price target?
Price Target
13.26 USD

According to Wall Street analysts, the average 1-year price target for VTGN is 13.26 USD with a low forecast of 12.12 USD and a high forecast of 15.75 USD.

What is VistaGen Therapeutics Inc's Revenue forecast?
Projected CAGR
186%

The compound annual growth rate of VistaGen Therapeutics Inc's revenue for the next 4 years is 186%.

Back to Top